Nicox: 2024 Ordinary Shareholder Meeting to be held on June 28th, 2024
Press Release Nicox: 2024 Ordinary Shareholder Meeting to be held on June 28th, 2024 May 24, 2024 – release at…
Invalda INVL plans offering of bonds this year
Invalda INVL has engaged AB Šiaulių bankas and UAB FMĮ INVL Financial Advisors to assess the possibilities of borrowing on…
Construction contract in Lithuania (wind farm balance of plant in Telšiai)
On 23 May 2024 entered into force a contract signed between UAB Merko Statyba, part of AS Merko Ehitus group,…
EVS invites Its shareholders to an Extraordinary General Meeting on June 10, 2024
Publication on May 24, 2024, at 6:30 am before market openingRegulated informationEVS Broadcast Equipment S.A.: Euronext Brussels (EVS.BR), Bloomberg (EVS…
Introducing Optimum AI: Revolutionizing DeFi with Text-Based Trading on WhatsApp and Telegram
Optimum AI – simplifying DeFi one message at a time New York, NY, May 23, 2024 (GLOBE NEWSWIRE) — Optimum…
Adlai Nortye Ltd. to Present Encouraging Data of the Combination of AN0025 and Definitive Chemoradiotherapy (dCRT) at ASCO 2024
SINGAPORE and NORTH BRUNSWICK, N.J. and HANGZHOU, China, May 23, 2024 (GLOBE NEWSWIRE) — Adlai Nortye Ltd. (NASDAQ: ANL) (the “Company” or…
HUTCHMED Highlights Presentations at the 2024 ASCO Annual Meeting
HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., May 23, 2024 (GLOBE NEWSWIRE) — HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM;…
Elevating Scientific Rigor with Umbrella Labs’ Gonadorelin Peptide and Precision Calculator
Tucson, May 23, 2024 (GLOBE NEWSWIRE) — Tucson, Arizona – Revolutionizing Peptide Studies with Umbrella Labs’ Innovative Calculator – The…
Restaurants Canada Expresses Concern as BC Restaurants Brace for Chicken Price Surge
Toronto, May 23, 2024 (GLOBE NEWSWIRE) — Restaurants Canada is deeply concerned about the increase in the price of live…
Mediacom Communications Ready to Connect Customers in First Phase of 221-Mile Seminole County Fiber Network Buildout
State Funded Broadband Grant Project Set to Serve 2,338 Homes and Businesses DONALSONVILLE, Ga., May 23, 2024 (GLOBE NEWSWIRE) —…
Associa Recognized as a US Best Managed Company
DALLAS, Texas, May 23, 2024 (GLOBE NEWSWIRE) — Associa is proud to announce it has been selected as a 2024…
Coherus Presents Preliminary Results from Phase I Dose Escalation Study of its Anti-chemokine receptor 8 (CCR8) Antibody, CHS-114, at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
CHS-114 shown to have an acceptable safety profile with no dose-limiting toxicities (DLTs) in heavily pretreated patients with solid tumors…
↑